A) Einfluss von Metallionen auf die Kristallbildung und Calcifikation.
2.
BirdE. D., ThomasW. C.Jr.: Effect of various metals on mineralization in vitro. Proc. Soc. exp. Biol., 112; 640–643 (1963).
3.
EusebioE., ElliottJ. S.: Effect of trace metals on the crystallization of calcium oxalate. Invest. Urol., 4; 431–435 (1967).
4.
FleischH. S., BisazS., RussellR. G. G.: The activating effect of lead on the precipitation of calcium phosphate Proc. Soc. Exp. Biol. Med., 118; 882–884(1965).
5.
GutmanA. B., YüT. F.: Metabolic interrelations. Trans 1st Conf. Josiah Macy, Jr., Foundation, New York 11 (1949).
6.
HochF. L., ValleeB. L.: J. Biol. Chem., 181; 295 (1949).
MukaiT., HowardJ. E.: Some observations on the calcification of rachitic cartilage by urine: one difference between «good» and «evil» urines, dependent upon content of magnesium. Bull. Johns Hopkins Hosp., 112; 279–290 (1963).
9.
OreopoulosD. G., SoyannwoA. O., McGeownM. D.: Magesium-calcium ratio in urine of patients with renal stones. Lancet, 23; 420–422 (1968).
10.
SadasivanV.: Studies on the biochemistry of zinc. Biochem. J., 48; 527–530 (1951).
11.
SobelA. E., GoldfarbA. R., KramerB.: Studies of incurable rickets II Role of the «local factor» and of viosterol in the pathogenesis of rickets due to beryllium. J. Biol. Chem., 108; 395–401 (1935).
12.
SobelA. E., CohenJ., KramerB.: The nature of the injury to the calcifying mechanism in rickets due to strontium. Biochem. J., 29; 2640–2645 (1935).
13.
SuttonR. A., WatsonL.: Urinary magnesium and renal stones. Lancet, 2; 636 (1968).
14.
TabasakiE., ShimanoE.: The urinary excretion of oxalic acid and magnesium in oxalate urolithiasis. Invest. Urol., 5; 303–312 (1967).
15.
B) Kristallwachstumsinhibitoren.
16.
CareA. D., NolanB.: The suppression of urinary calculus formation in the rat by the oral administration of polysodium metaphosphate. Brit. J. Urol., 32; 312–319 (1960).
17.
CareA. D., WilsonG.: The prevention of vesical calculi in rats by the oral administration of polysodium metaphosphate. Clin. Sci., 15; 183–193 (1956).
18.
CrawfordJ. E., CrematyE. P., AlexanderA. E.: Aust. J. Chem., 21; 1067 (1968).
19.
DentC. E., SutorD. J.: Lancet, 2; 775–778 (1971).
20.
FelixR., BisarS., HansenN. M., FleischH.: Aggregation and disaggregation of hydroxy apatite crystals in: Urolithiasis Research, Eds FleischH., RobertsonW. G., SmithL. H., and VahlensieckW., 265–268, Plenum Press, New York-London1976.
21.
FleischH., BisarS.: Isolation from urine of pyrophosphate, a calcification inhibitor. Amer. J. Physiol., 203; 671–675 (1962).
22.
FleischH., BisarS.: Mechanism of calcification: inhibitory role of pyrophosphate. Nature, 195; 911 (1962).
23.
FleischH., BisazS.: The inhibitory effect of pyrophosphate on calcium oxalate precipitation and its relation to urolithiasis. Experientia, 20; 276–277 (1969).
24.
FleischH., BisazS.: Die Pyrophosphatausscheidung im Harn beim gesunden Menschen. Helv. physiol. pharmacol. Acta, 21; 88–94 (1963).
25.
FleischH., BisazS., CareA. D.: Effect of orthophosphate on urinary pyrophosphate excretion and the prevention of urolithiasis. Lancet, 1; 1065–1067 (1969).
26.
FleischH., MonodA.: A new technique for measuring aggregation of calcium oxalate crystals in vitro: effect of urine, magnesium, pyrophosphate and diphosphonates. Urinary Calculi. Intern. Symp. Renal Stone Res., Madrid, 1972, 53–56, Karger, Basel 1973.
27.
FleischH., BisazS.: Mechanism of calcification: inhibitory role of pyrophosphate. Nature, 195; 911 (1962).
28.
FleischH., BisazS., RussellR. G. G.: Urol. intern., 22; 483 (1967).
29.
FrancisM. D., RussellR. G. G., FleischH.: Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science, 165; 1264–1266 (1969).
GillW. B., KareshJ. W.: Demonstration of protective (inhibitory) effects of urinary macromolecules on the crystallization of calcium oxalate, in: Urolithiasis research, Eds. FleischH., RobertsonW. G., SmithL. H., and VahlensieckW., Plenum Press, New York-London1976.
32.
HodkinsonA., PyrahL. N.: The urinary excretion of calcium and inorganic phosphate in 349 patients with calcium stone of renal origin. Brit. J. Surg., 46; 10–18 (1958).
HowardJ. E., ThomasW. C., BarkerL. M., SmithL. H., WadkinsC. L.: The recognition and isolation from urine and serum of a peptide inhibitor to calcification. Johns Hopk. med. J., 120; 119–136 (1967).
35.
HowardJ. E., ThomasW. C.Jr.: Some observations on rachitic rat cartillage of probable significance in the etiology of renal calculi. Trans. Amer. Clin. Climatol. Assoc, 70; 94–102 (1958).
36.
HowardJ. E., ThomasW. C.Jr., SmithL. H., BarkerL. M., WadkinsC. L.: A urinary peptide with extraordinary inhibitory power against biological «calcification». Trans. Assoc. Amer. Physicians, 69; 137–144 (1966).